ELOX 424B3: Board change

Filed with the SEC on · accession 0001193125-26-428120

ELOX filed a 424B3 (prospectus (offering)) with the SEC on Oct 22, 2026. Eloxx Pharmaceuticals increased its Board of Directors from five to six members and appointed Geno J. The stock moved -1.1% by the first close after the filing.

Summary of the filing

Eloxx Pharmaceuticals increased its Board of Directors from five to six members and appointed Geno J. Germano, a 35-year pharmaceutical industry veteran, to fill the newly created vacancy. The appointment was disclosed via a prospectus supplement updating a prior Form 8-K.

Key details

IssuerEloxx Pharmaceuticals, Inc.
Former employer of appointeeElucida Oncology, Inc.
Former employer of appointeePfizer
DirectorGeno J. Germano

How ELOX stock reacted

Close before

$13.27

Oct 21, 2026

First close after

-1.13%

$13.12

5 trading days

-1.13%

$13.12

Since filing

-5.80%

$12.50

✦ Ask GOAX AI about this filing — what it means for ELOX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ELOX?

Click here

Frequently asked questions

What did ELOX file with the SEC on Oct 22, 2026?

ELOX filed a 424B3 (Board change). Eloxx Pharmaceuticals increased its Board of Directors from five to six members and appointed Geno J. Germano, a 35-year pharmaceutical industry veteran, to fill the newly created vacancy. The appointment was disclosed via a prospectus supplement updating a prior Form 8-K.

What does a board change mean for ELOX stock?

Not always. A planned retirement with a successor is usually calm; a sudden departure “effective immediately”, especially of a CFO or near results, often worries investors.

How do I read a 424B3?

The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B3 (prospectus (offering)): The final terms of an offering of shares or bonds.

How did ELOX stock react to this filing?

ELOX closed at $13.27 before the filing and $13.12 on Oct 22, 2026 (-1.13%). Five trading days later: $13.12 (-1.13%).

Other ELOX SEC filings

Get alerts when ELOX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days